INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Reducing Human Variability in Bioanalysis
Automation removes manual variability, creating consistent, repeatable processes that improve precision, strengthen compliance, and produce more reliable data for critical decisions.
-
CRO Selection Science: Insights From $2B+ Vendor Choices
Discover how data-driven strategies and structured RFPs can simplify CRO selection, improve transparency, and ensure the right operational fit. Learn practical steps to make smarter vendor decisions.
-
Subject Matter Experts Matter In Decision-Making
Expert-led ontology and taxonomy practices help organize data into meaningful hierarchies, making it easier to connect diseases, drug targets, and strategic insights that support stronger decisions.
-
Building A High-Quality IND From Scratch With Strategic Gap Analysis
A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).
-
From Frustration To Organization: An SSO Platform For Trial Sites5/2/2025
To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
-
The Bioanalysis Report You Actually Get Back Fast3/9/2026
Manual bioanalysis variability creates data noise. Automation replaces inconsistencies with repeatable processes that boost precision, support compliance, and deliver more reliable results.
-
The Case For Parallel Processing In Clinical Trial Start-Up1/26/2026
Stop letting outdated processes stall your innovation and learn how parallel processing transforms study start-up from a series of hurdles into a synchronized sprint.
-
Unlocking The Benefits Of Site Payment Platforms: Part 112/5/2025
By standardizing workflows, ensuring audit-ready documentation, and providing actionable real-time insights, these platforms mitigate operational risks while supporting better financial oversight.
-
Participant Payments Without Site Burden6/16/2026
Participant payments can create extra work for clinical trial sites. Learn how clearer ownership, connected workflows, and direct support reduce site burden while preserving visibility.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
Unearth the ways Advarra Consulting Institutional Center of Excellence's specialized research professionals are helping organizations reach their goals for lasting success.
-
Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.